Objective: Skin-sodium storage, as a physiologically important regulatory mechanism for blood pressure, volume regulation, and indeed survival, has recently been rediscovered. This prompted the development of MRI methods to assess sodium storage in humans ( 23 Na-MRI) at 3.0 Tesla. This work examines the feasibility of high in-plane spatial resolution 23 Na MRI in skin at 7.0 T. Methods:A two-channel transceiver RF coil array tailored for skin MRI at 7.0 T (f=78.5MHz) is proposed. Specific absorption rate (SAR) simulations and a thorough assessment of RF power deposition were performed to meet the safety requirements. Human skin was examined in an in vivo feasibility study using 2D gradient echo imaging. Normal male adult volunteers (n=17, mean ± SD = 46 ± 18 years, range: 20-79 years) were investigated.Transverse slices of the calf were imaged with 23 Na MRI using a high in-plane resolution of (0.9 x 0.9) mm 2 . Skin Na + content was determined using external agarose standards covering a physiological-range of Na + concentrations. To assess the intra-subject reproducibility, each volunteer was examined three to five times with each session including a 5 min walk and repositioning/preparation of the subject. Age-dependence of skin Na + content was investigated. Results:The 23 Na RF coil provides improved sensitivity within a range of 1 cm from its surface versus a volume RF coil which facilitates high in-plane spatial resolution imaging of human skin. Intra-subject variability of human skin sodium content in the volunteer population was <10.3%. An age-dependent increase in skin Na + content was observed, r = 0.78). Short abstractThis work demonstrates the feasibility of sub-millimeter in-plane spatial resolution 23 Na MRI in skin at clinically acceptable acquisition times at 7.0 T. Intra-subject variability of human skin sodium content in the volunteer population was <10.3%. An age-dependent increase in skin Na + content was observed (r = 0.78). Assigning sodium stores with 23 Na-MRI techniques could be improved at 7.0 T compared to current 3.0 T technology.-6 -
The objective of this work was to examine the feasibility of three-dimensional (3D) and whole heart coverage (23)Na cardiac MRI at 7.0 T including single-cardiac-phase and cinematic (cine) regimes. A four-channel transceiver RF coil array tailored for (23)Na MRI of the heart at 7.0 T (f = 78.5 MHz) is proposed. An integrated bow-tie antenna building block is used for (1)H MR to support shimming, localization and planning in a clinical workflow. Signal absorption rate simulations and assessment of RF power deposition were performed to meet the RF safety requirements. (23) Na cardiac MR was conducted in an in vivo feasibility study. 3D gradient echo (GRE) imaging in conjunction with Cartesian phase encoding (total acquisition time T(AQ) = 6 min 16 s) and whole heart coverage imaging employing a density-adapted 3D radial acquisition technique (T(AQ) = 18 min 20 s) were used. For 3D GRE-based (23)Na MRI, acquisition of standard views of the heart using a nominal in-plane resolution of (5.0 × 5.0) mm(2) and a slice thickness of 15 mm were feasible. For whole heart coverage 3D density-adapted radial (23)Na acquisitions a nominal isotropic spatial resolution of 6 mm was accomplished. This improvement versus 3D conventional GRE acquisitions reduced partial volume effects along the slice direction and enabled retrospective image reconstruction of standard or arbitrary views of the heart. Sodium cine imaging capabilities were achieved with the proposed RF coil configuration in conjunction with 3D radial acquisitions and cardiac gating. Cardiac-gated reconstruction provided an enhancement in blood-myocardium contrast of 20% versus the same data reconstructed without cardiac gating. The proposed transceiver array enables (23)Na MR of the human heart at 7.0 T within clinical acceptable scan times. This capability is in positive alignment with the needs of explorations that are designed to examine the potential of (23)Na MRI for the assessment of cardiovascular and metabolic diseases.
Vol. 57Dihydrocerin (Cerinol).-One and one-half grams of cerin in 100 ml. of «-amyl alcohol was reduced by adding 3 g. of sodium to the hot solution over a period of fifteen minutes. After the sodium had dissolved completely, the alcohol was removed by steam distillation and the product recrystallized from dioxane. The dicarbinol, for which we propose the name cerinol, crystallized from dioxane in narrow white laths, which melted at 293-295°;[<& +9-4 (C = 0.48).
BackgroundThe implementation of magnetic resonance imaging (MRI) guided radiotherapy (RT) continues to increase. Very limited in-vitro data on the interaction of ionizing radiation and magnetic fields (MF) have been published. In these experiments we focused on the radiation response in a MF of the TK6 human lymphoblastoid cells which are known to be highly radiosensitive due to efficient radiation-induced apoptosis.MethodsClonogenicity was determined 12–14 days after irradiation with 1–4 Gy 6 MV photons with or without a 1.0 Tesla MF. Furthermore, alterations in cell cycle distribution and rates of radiation induced apoptosis (FACS analysis of cells with sub-G1 DNA content) were analyzed.ResultsClonogenic survival showed an exponential dose-dependence, and the radiation sensitivity parameter (α = 1.57/Gy) was in accordance with earlier reports. Upon comparing the clonogenic survival between the two groups, identical results within error bars were obtained. The survival fractions at 2 Gy were 9% (without MF) and 8.5% (with MF), respectively.ConclusionA 1.0 Tesla MF does not affect the clonogenicity of TK6 cells irradiated with 1–4 Gy 6MV photons. This supports the use of MRI guided RT, however ongoing research on the interaction of MF and radiotherapy is warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.